Journal article
Pro-GRP-derived peptides are expressed in colorectal cancer cells and tumors and are biologically active in vivo
O Patel, D Clyde, M Chang, MS Nordlund, R Steel, BE Kemp, DM Pritchard, A Shulkes, GS Baldwin
Endocrinology | Published : 2012
DOI: 10.1210/en.2011-1875
Abstract
Amidated gastrin-releasing peptide (GRP) is the prototypical autocrine growth factor. Nonamidated peptides derived from the C terminus of pro-GRP are also biologically active in colorectal cancer (CRC) cell lines in vitro, via a receptor distinct from the GRP receptor. The aims of this study were to measure the amounts of pro-GRP-derived peptides in human CRC cell lines and tumors, characterize the immunoreactive peptide, and investigate its effect on proliferation in vitro and in vivo. Pro-GRP-derived peptides were quantitated by region-specific ELISA in extracts of five human CRC cell lines and 20 tumors. The immunoreactive material was purified by HPLC and its mass and sequence establishe..
View full abstractGrants
Funding Acknowledgements
This work was supported by grants from the National Health and Medical Research Council of Australia (O.P., A.S., G.S.B.), the Austin Health Medical Research Foundation (O.P.), and the North West Cancer Research Fund (D.C., D.M.P.).